ROSEN, A LEADING, LONGSTANDING, AND TOP RANKED FIRM, Encourages Veru Inc. Investors to Inquire About Securities Class Action Investigation - VERUNewsfile Corp • 11/23/22
VERU, Inc. Investigated by Block & Leviton For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the FirmNewsfile Corp • 11/22/22
VERU INVESTIGATION: Hagens Berman, National Trial Attorneys, Encourages Veru Inc. (VERU) Investors with Losses to Contact Firm's Attorneys, Firm Investigating Possible Securities Law ViolationsNewsfile Corp • 11/17/22
VERU BREAKING NEWS: ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Veru Inc. Investors to Inquire About Securities Class Action Investigation - VERUPRNewsWire • 11/16/22
ONGOING INVESTIGATION REMINDER: The Schall Law Firm Announces It Is Investigating Claims Against Veru Inc. and Encourages Investors with Losses to Contact the FirmNewsfile Corp • 11/15/22
VERU ALERT: Bragar Eagel & Squire, P.C. is Investigating Veru Inc. on Behalf of Veru Stockholders and Encourages Investors to Contact the FirmBusiness Wire • 11/15/22
ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces It Is Investigating Claims Against Veru Inc. and Encourages Investors with Losses to Contact the FirmNewsfile Corp • 11/14/22
INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Veru Inc. and Encourages Investors with Losses to Contact the FirmBusiness Wire • 11/11/22
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Veru Inc. and Encourages Investors with Losses to Contact the FirmAccesswire • 11/10/22
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Veru Inc. and Encourages Investors with Losses to Contact the FirmBusiness Wire • 11/10/22
Veru Stock Plummets 65% After FDA Advisors Vote Down Cancer-Turned-Covid DrugInvestors Business Daily • 11/10/22
Veru Provides Update on FDA Advisory Committee Meeting Regarding Emergency Use Authorization of Sabizabulin to Treat Hospitalized COVID-19 Patients at High Risk for Acute Respiratory Distress SyndromeGlobeNewsWire • 11/10/22
Strength Seen in Veru Inc. (VERU): Can Its 39.5% Jump Turn into More Strength?Zacks Investment Research • 11/08/22
Medical Leader Veru Catapults As FDA Preps To Discuss Cancer Drug For CovidInvestors Business Daily • 11/07/22
Veru Announces Late-Breaker Oral Presentation of Sabizabulin Treatment for Hospitalized Adults with COVID-19 on Supplemental Oxygen at Infectious Disease Week 2022GlobeNewsWire • 10/24/22
Veru to Present Late-Breaker Oral Presentation of Sabizabulin Treatment for Hospitalized Adults with COVID-19 on Supplemental Oxygen at Infectious Disease Week 2022GlobeNewsWire • 10/13/22